Advertisements


Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Mateon.....»»

Category: earningsSource: benzingaApr 16th, 2018

Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018

CRANBURY, N.J., .....»»

Category: earningsSource: benzingaDec 18th, 2018

Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results

WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the thi.....»»

Category: earningsSource: benzingaNov 7th, 2018

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results

-Obtained Approvals of CTAs in Multiple Countries for CTX001 in β-thalassemia and SCD--Initiation of Clinical Trials for CTX001 in β-thalassemia and SCD on Track for 2018--Preclinical Studies for CTX110 Targeting CD19+ Malignancies Ha.....»»

Category: earningsSource: benzingaAug 7th, 2018

Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results

WARREN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ.....»»

Category: earningsSource: benzingaAug 1st, 2018

Unum Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update

– Successfully Completed IPO and Concurrent Private Placement Raising $77 Million in Gross Proceeds – – Initiated Cohort Expansion of ATTCK-20-2 Phase I T.....»»

Category: earningsSource: benzingaMay 14th, 2018

Galectin Therapeutics Reports 2018 First Quarter Financial Results and Provides Business Update

NORCROSS, Ga., May 11, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today reported financial re.....»»

Category: earningsSource: benzingaMay 11th, 2018

Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results

WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today prov.....»»

Category: earningsSource: benzingaMay 10th, 2018

FuelCell Energy Reports Fourth Quarter and Fiscal 2018 Financial Results and Business Update

New $100+ million construction financing secured in December First of three Long Island Power Authority PPAs signed Connecticut project awards totaling 22.2 megawatts now under PPA Record backlog and project awards of nearly $2 billion DANBURY, Conn......»»

Category: earningsSource: benzingaJan 10th, 2019

Therapix Biosciences Reports Third Quarter 2018 Financial Results and Provides Business Update

TEL AVIV, Israe.....»»

Category: earningsSource: benzingaDec 3rd, 2018

Emerald Health Therapeutics Reports 3rd Quarter 2018 Financial Results and Provides Corporate Update

VICTORIA, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX.....»»

Category: earningsSource: benzingaNov 30th, 2018

CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update

CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaNov 29th, 2018

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2018 Financial Results

Conference call today at 8:00 a.m. ET NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-st.....»»

Category: earningsSource: benzingaNov 15th, 2018

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results

REDWOOD CITY, Calif., N.....»»

Category: earningsSource: benzingaNov 15th, 2018

Net Element Reports Third Quarter 2018 Financial Results and Provides Business Update

Net Element Reports Third Quarter 2018 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaNov 14th, 2018

Mateon Therapeutics Reports Third Quarter 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology i.....»»

Category: earningsSource: benzingaNov 14th, 2018

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

Category: earningsSource: benzingaNov 14th, 2018

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmac.....»»

Category: earningsSource: benzingaNov 13th, 2018

Cellectar Reports Third Quarter 2018 Financial Results and Provides Business Update

FLORHAM PARK, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB) ("Cell.....»»

Category: earningsSource: benzingaNov 13th, 2018

Neon Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights

Data presented at ESMO and SITC underscore continued clinical progress across platform and pipeline CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (NASDAQ:NTGN), a clinical-stage immuno-oncology compa.....»»

Category: earningsSource: benzingaNov 12th, 2018

ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update

Phase 3 trial for eryaspase in second line pancreatic cancer enrolling patients Phase 2 trial in triple-negative breast cancer to enroll patients by year end Cash position of €146.9 million ($170 million) as of September 30, 2018 LYON, France and CAM.....»»

Category: earningsSource: benzingaNov 12th, 2018